IN2014KN02722A - - Google Patents

Info

Publication number
IN2014KN02722A
IN2014KN02722A IN2722KON2014A IN2014KN02722A IN 2014KN02722 A IN2014KN02722 A IN 2014KN02722A IN 2722KON2014 A IN2722KON2014 A IN 2722KON2014A IN 2014KN02722 A IN2014KN02722 A IN 2014KN02722A
Authority
IN
India
Prior art keywords
purification
preparation
processes
efficient
high quality
Prior art date
Application number
Other languages
English (en)
Inventor
Wayne D Luke
Steffen Jost
Original Assignee
Phosplatin Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phosplatin Therapeutics Llc filed Critical Phosplatin Therapeutics Llc
Publication of IN2014KN02722A publication Critical patent/IN2014KN02722A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN2722KON2014 2012-05-24 2013-03-15 IN2014KN02722A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261651200P 2012-05-24 2012-05-24
PCT/US2013/031885 WO2013176764A1 (en) 2012-05-24 2013-03-15 Synthetic and purification methods for phosphaplatin compounds and uses thereof

Publications (1)

Publication Number Publication Date
IN2014KN02722A true IN2014KN02722A (pt) 2015-05-08

Family

ID=49624225

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2722KON2014 IN2014KN02722A (pt) 2012-05-24 2013-03-15

Country Status (18)

Country Link
US (2) US8846964B2 (pt)
EP (2) EP3202769B1 (pt)
JP (1) JP5833795B2 (pt)
CN (2) CN104540839B (pt)
CY (2) CY1118746T1 (pt)
DK (2) DK3202769T3 (pt)
ES (2) ES2751668T3 (pt)
HK (1) HK1203202A1 (pt)
HR (2) HRP20170416T1 (pt)
HU (2) HUE032197T2 (pt)
IN (1) IN2014KN02722A (pt)
LT (2) LT2855496T (pt)
PL (2) PL3202769T3 (pt)
PT (2) PT3202769T (pt)
RS (2) RS55806B1 (pt)
SI (2) SI3202769T1 (pt)
TW (2) TWI653237B (pt)
WO (1) WO2013176764A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2751668T3 (es) * 2012-05-24 2020-04-01 Phosplatin Therapeutics Llc Método de purificación para compuestos de fosfaplatino
AU2017246883B2 (en) * 2016-04-06 2023-02-09 Promontory Therapeutics Inc. Phosphaplatin liquid formulations
CN110381952B (zh) * 2017-01-06 2023-10-20 弗斯普拉廷治疗有限公司 作为治疗剂用于治疗骨癌或血癌的磷铂化合物
WO2019051246A1 (en) * 2017-09-08 2019-03-14 Phosplatin Therapeutics Llc PHOSPHAPLATINE COMPOUNDS AS IMMUNOMODULATORS AND THERAPEUTIC USES THEREOF
CN113861036B (zh) * 2021-11-08 2024-04-02 合肥工业大学 一种乙二胺高氯酸铜配合物的制备及用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234500A (en) 1979-03-07 1980-11-18 Engelhard Minerals & Chemicals Corporation Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
WO2005000858A2 (en) 2003-06-27 2005-01-06 Akira Odani Bisphosphonate complexes
BRPI0708004A2 (pt) * 2006-01-30 2011-05-17 Platco Technologies Proprietary Ltd preparação de complexos de platina (ii)
KR20100020008A (ko) * 2007-05-18 2010-02-19 티티아이 엘뷰 가부시키가이샤 생물학적 인터페이스를 통한 활성 성분의 방출을 개선한 경피 전달 장치
SI2173337T1 (sl) * 2007-08-06 2014-10-30 Ohio University Fosfaplatini in njihova uporaba pri zdravljenju vrst raka, odpornih proti cisplatinu in karboplatinu
EP2575802B1 (en) 2010-06-04 2016-11-16 Ohio University Phosphaplatins and their use for treatment of cancers
US9012669B2 (en) * 2011-10-05 2015-04-21 The University Of Houston System Efficient processes for large scale preparation of phosphaplatins antitumor agents
ES2751668T3 (es) * 2012-05-24 2020-04-01 Phosplatin Therapeutics Llc Método de purificación para compuestos de fosfaplatino

Also Published As

Publication number Publication date
LT3202769T (lt) 2019-12-10
LT2855496T (lt) 2017-04-10
RS55806B1 (sr) 2017-08-31
HK1203202A1 (en) 2015-10-23
US20140024848A1 (en) 2014-01-23
EP2855496A4 (en) 2015-04-08
TWI599361B (zh) 2017-09-21
TW201347765A (zh) 2013-12-01
HRP20170416T1 (hr) 2017-05-19
HUE046327T2 (hu) 2020-03-30
PT3202769T (pt) 2019-10-31
US20140288321A1 (en) 2014-09-25
HRP20191904T1 (hr) 2020-01-24
CN106967124A (zh) 2017-07-21
US8859796B1 (en) 2014-10-14
HUE032197T2 (en) 2017-09-28
CY1118746T1 (el) 2018-03-07
SI2855496T1 (sl) 2017-04-26
ES2751668T3 (es) 2020-04-01
PL2855496T3 (pl) 2017-09-29
ES2619412T3 (es) 2017-06-26
EP2855496A1 (en) 2015-04-08
RS59725B1 (sr) 2020-01-31
TWI653237B (zh) 2019-03-11
PL3202769T3 (pl) 2020-03-31
EP3202769B1 (en) 2019-10-02
JP2015523335A (ja) 2015-08-13
CY1122316T1 (el) 2021-01-27
US8846964B2 (en) 2014-09-30
SI3202769T1 (sl) 2020-02-28
EP3202769A1 (en) 2017-08-09
DK2855496T3 (en) 2017-03-27
DK3202769T3 (da) 2019-10-28
PT2855496T (pt) 2017-03-23
JP5833795B2 (ja) 2015-12-16
CN106967124B (zh) 2020-03-06
EP2855496B1 (en) 2016-12-14
CN104540839A (zh) 2015-04-22
WO2013176764A1 (en) 2013-11-28
TW201741326A (zh) 2017-12-01
CN104540839B (zh) 2017-02-22

Similar Documents

Publication Publication Date Title
IN2015KN00262A (pt)
EA201492165A1 (ru) Синтез пирроло[2,3-b]пиридинов
MX2016012419A (es) Formas solidas de ibrutinib y procesos para la produccion de las mismas.
MX344521B (es) Aminas heterociclicas y sus usos.
PH12015500376B1 (en) Novel bicyclic pyridinones
PH12014501991B1 (en) Phenicol antibacterials
IN2014DN09085A (pt)
EA201790916A1 (ru) Новые лиганды rig-i и способы их получения
IN2012MU03723A (pt)
WO2014178078A3 (en) Novel cloning, expression & purification method for the preparation of ranibizumab
EP2801611A4 (en) MICRO-ORGANISM FOR THE PRODUCTION OF L-AMINO ACID AND PROCESS FOR THE PRODUCTION OF L-AMINO ACIDS THEREWITH
IN2015KN00323A (pt)
EP2713730A4 (en) PROCESS FOR THE PREPARATION OF SAXAGLIPTIN AND ITS NEW INTERMEDIATES USEFUL IN ITS SYNTHESIS
CY1122316T1 (el) Μεθοδοι συνθεσης και καθαρισμου για ενωσεις φωσφαπλατiνης και χρησεις αυτων
MY194466A (en) Heterophasic polypropylene composition
MX369662B (es) Granulos de harina de microalgas y proceso de preparacion de estos.
GEP201706626B (en) Synthesis of (s)-nifuratel
IN2013CH04906A (pt)
GB201107985D0 (en) Process
MX2013013436A (es) Derivados de indol sustituidos para el tratamiento de transtornos inmunologicos.
TR201902152T4 (tr) Metiltioninyum klorür (mtc) bulunan diaminofenotiazinyum bileşiklerinin kimyasal sentezi için yöntemler.
PH12014501367A1 (en) Processes for making magnolol and derivatives thereof
IN2014DN07407A (pt)
MX2014004210A (es) Derivados de 2-oxo-piperidinilo.
IN2012CH02984A (pt)